You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
遠大醫藥(00512.HK)聯營核心產品期取得兩項重大進展
阿思達克 03-08 18:18
遠大醫藥(00512.HK)公布,集團之聯營公司 Sirtex Medical Pty Ltd 的核心產品SIR-Spheres釔[90Y]樹脂微球近期取得兩項重大進展,包括獲英國國家健康照護專業組織 National Institute for Health and Care Excellence推薦用於治療不可切除的晚期肝細胞癌成人患者,以及獲美國食品藥品管理局(FDA)批准開展原發性肝癌臨床試驗,以在美國申請原發性肝癌的上市許可,再一次證明了該產品的臨床療效和競爭優勢,有助於幫助全球範圍內更多肝癌患者接受SIR-Spheres釔[90Y]樹脂微球治療。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account